Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Markus Niggli, PhD
JCP
Original Research
Decoglurant for MDD Treatment
July 14, 2020
Read study discussing the treatment of MDD through modulation of dysregulated glutamate neurotransmission.
Daniel Umbricht
,
Markus Niggli
,
Patricia Sanwald-Ducray
, et al
